Search research articles
Contact Us
Filters
Showing results (271-280 of 279) with videos related to
Page
of 28
Sort By:
You have reached the last page of results.
This site can display upto 279 results.
Journal of Medicinal Chemistry
|
July 24, 2008
Identification of 4-aminopyrazolylpyrimidines as potent inhibitors of Trk kinases
Tao Wang, Michelle L Lamb, David A Scott, et al.
Journal of Medicinal Chemistry
|
December 11, 2013
Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582)
Edward J Hennessy, Ammar Adam, Brian M Aquila, et al.
Molecular and Cellular Biology
|
January 7, 1998
A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis
R E Barrington, M A Subler, E Rands, et al.
Cancer Research
|
December 26, 2001
Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models
R B Lobell, C A Omer, M T Abrams, et al.
African Journal of Reproductive Health
|
December 6, 2023
Comparing the safety and effectiveness of various umbilical cord milking techniques and delayed cord clamping in full-term and preterm infants: A systematic review and meta-analysis
Amal Y Zaman, Hammad A Fadlalmola, Amani A Mohammed, et al.
Journal of Medicinal Chemistry
|
August 25, 2001
Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency
I M Bell, S N Gallicchio, M Abrams, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 4, 2023
Biallelic variants in CRIPT cause a Rothmund-Thomson-like syndrome with increased cellular senescence
Luisa Averdunk, Maxim A Huetzen, Daniel Moreno-Andrés, et al.
Cancer Research
|
May 29, 2000
Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor
C A Omer, Z Chen, R E Diehl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 10, 2018
High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
Asaf D Yanir, Imelda C Hanson, William T Shearer, et al.
Page
of 28
Search research articles
Search
Showing results (271-280 of 279) with videos related to
Sort By:
Page
of 28
You have reached the last page of results.
This site can display upto 279 results.
Journal of Medicinal Chemistry
|
July 24, 2008
Identification of 4-aminopyrazolylpyrimidines as potent inhibitors of Trk kinases
Tao Wang, Michelle L Lamb, David A Scott, et al.
Journal of Medicinal Chemistry
|
December 11, 2013
Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582)
Edward J Hennessy, Ammar Adam, Brian M Aquila, et al.
Molecular and Cellular Biology
|
January 7, 1998
A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis
R E Barrington, M A Subler, E Rands, et al.
Cancer Research
|
December 26, 2001
Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models
R B Lobell, C A Omer, M T Abrams, et al.
African Journal of Reproductive Health
|
December 6, 2023
Comparing the safety and effectiveness of various umbilical cord milking techniques and delayed cord clamping in full-term and preterm infants: A systematic review and meta-analysis
Amal Y Zaman, Hammad A Fadlalmola, Amani A Mohammed, et al.
Journal of Medicinal Chemistry
|
August 25, 2001
Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency
I M Bell, S N Gallicchio, M Abrams, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 4, 2023
Biallelic variants in CRIPT cause a Rothmund-Thomson-like syndrome with increased cellular senescence
Luisa Averdunk, Maxim A Huetzen, Daniel Moreno-Andrés, et al.
Cancer Research
|
May 29, 2000
Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor
C A Omer, Z Chen, R E Diehl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 10, 2018
High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
Asaf D Yanir, Imelda C Hanson, William T Shearer, et al.
Page
of 28